patient safety

Pharmalot By Ed Silverman

Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds

Pharmalot By Ed Silverman

High blood pressure pills are costly — but also hard to find — in some lower-income countries

Health By Lauran Neergaard — Associated Press

FDA clears Covid booster shot for healthy kids ages 5 to 11

Health By Usha Lee McFarling

National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials

D.C. Diagnosis By Nicholas Florko

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

Pharmalot By Ed Silverman

Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver

First Opinion By Danielle Wenner and Gabriela Arguedas Ramírez

Omitting long Covid from pandemic messaging is harmful for public health

First Opinion By Joe Lieberman and Michelle McMurry-Heath

Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures